PMCPA Case Library

Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.

1,930
Cases
291
Companies
154
Clauses
6
Code Versions

or browse all 154 ABPI clause guides ↗

Case Library Membership

Filter by Company & ABPI Clause

Search free — but unlock advanced filters to find every case involving a specific company or clause.

Filter 1,930+ cases by any of 291 companies
Filter by any of 154 ABPI Code clauses
Filter by Code version (2016, 2019, 2021…)
Full-text keyword search across all cases
Cancel any time

Already a member? Sign in →

Case Library Membership

Best value
£249 /year Save £99

inc. VAT

£29 /month

inc. VAT · cancel any time

Unlock Full Access →

Secure payment via Stripe


Need access for your team?

Company licences available for compliance teams, medical affairs, and training programmes.

Get a team quote →

1,930 cases found

08
Mar 2026
2012 Code Janssen

AUTH/3070/9/18: Director v Johnson & Johnson (Janssen) — Clinical trial disclosure on EUCTR (no breach)

Following a BMJ analysis of EUCTR reporting, the PMCPA reviewed two Janssen trials shown as unreported. Both were cancelled with no patients…

08
Mar 2026
2015 Code Pharmasure Clause 18.1

AUTH/3008/1/18: Teva v Pharmasure – chocolate hamper provided to health professionals

A Pharmasure representative delivered a substantial high street chocolate hamper to a fertility unit team. The Panel ruled it was an unacceptable…

08
Mar 2026
2019 Code Janssen Clause 4 Clause 7 Clause 9

Janssen Medical Cloud website: out-of-date prescribing information in materials, misleading graph scale, and unqualified use of “safe”

A UK health professional complained about Janssen’s HCP website. The Panel found some prescribing information was out-of-date, one graph exaggerated differences, and…

08
Mar 2026
2019 Code Colonis Pharma

Colonis Pharma: promotional letter for Melatonin Oral Solution misleadingly implied product-specific support from general guidance

A promotional letter for Melatonin 1mg/ml Oral Solution cited general CCG/RPS guidance and “data on file” in a way that implied product-specific…

08
Mar 2026
2019 Code Teva UK

Teva DuoResp Spiromax BMJ-hosted digital ad ruled misleading and out of date

A UK health professional complained that a BMJ-hosted DuoResp Spiromax ad implied broader licensed use than permitted and relied on footnotes. The…

08
Mar 2026
2015 Code Bristol-Myers Squibb Pharmaceuticals Pfizer

Pfizer and Bristol-Myers Squibb: restaurant speaker meetings and concerns about privacy and hospitality (no breach)

Anonymous complaint about two restaurant-based promotional speaker meetings alleged public could overhear and hospitality was excessive. Panel found complainant did not prove…

08
Mar 2026
2019 Code Bristol-Myers Squibb Pharmaceuticals Pfizer Clause 2 Clause 9.1

Pfizer and Bristol-Myers Squibb: Eliquis promotion on Pulse email and microsite found misleading and missing prescribing information

A UK health professional complained about a Pulse promotional email and linked Eliquis VTE webpages. The email lacked prescribing information and a…

08
Mar 2026
2019 Code Bristol-Myers Squibb Pharmaceuticals Pfizer Clause 2 Clause 7 Clause 8 Clause 15

AUTH/3283/11/19 and AUTH/3284/11/19: CCG senior pharmacist v Bristol-Myers Squibb and Pfizer (Eliquis promotion and litigation comments)

Two Alliance representatives raised litigation/medico-legal consequences during a promotional meeting about Eliquis amid cost-driven switching to Lixiana. The Panel found scaremongering and…

08
Mar 2026
2019 Code Colonis Pharma Clause 1 Clause 2

AUTH/3239/8/19: Pharmacist v Colonis Pharma Limited – promotion of Melatonin Oral Solution and off-label implication

A pharmacist complained a launch letter promoted off-label use of Melatonin 1mg/ml Oral Solution. The Panel ruled the letter promoted off-label use,…

06
Mar 2026
2019 Code Merck Sharp & Dohme Clause 2

AUTH/3236/8/19: Health professional v Merck Sharp & Dohme – incorrect Disclosure UK transfer of value entry

A health professional challenged an incorrect Disclosure UK entry showing MSD provided financial support. The Panel found the disclosure inaccurate and misleading,…

05
Mar 2026
2019 Code Gilead Sciences Europe Clause 2 Clause 9 Clause 29

Gilead ruled in breach for failing to comply with an undertaking: Biktarvy tolerability claim remained on website

ViiV and the PMCPA Director complained that Gilead continued to display a Biktarvy tolerability claim on a UK-accessible website after giving an…

04
Mar 2026
2019 Code Allergan

Allergan: Botox pack shots and award reposts on Instagram found to promote a POM to the public

Allergan reposted Instagram Stories and employee posts that included Botox pack shots and an “Injectable Product of the Year” reference. The Panel…

03
Mar 2026
2019 Code Daiichi-Sankyo Clause 2

AUTH/3285/12/19: Ex-employee v Daiichi-Sankyo – Underreporting transfers of value on Disclosure UK

An ex-employee alleged Daiichi-Sankyo grossly underreported conference-related transfers of value on Disclosure UK (2016–2018). The Panel found multiple disclosure and record-keeping breaches,…

02
Mar 2026
2019 Code Colonis Pharma

Colonis voluntary admission: wrong prescribing information in promotional letter for Melatonin Oral Solution

Colonis admitted a promotional letter for Melatonin 1mg/ml Oral Solution included prescribing information for Melatonin 3mg tablets. The Panel ruled breaches including…

27
Feb 2026
2021 Code GSK UK Clause 25

GSK breach upheld on taskforce website: sponsorship not clearly acknowledged “from the outset” (Clause 25.3)

GSK funded a patient-organisation-hosted taskforce. PMCPA found sponsorship disclosure wasn’t clear “from the outset” because it was only accessible via small footer…

1124125126127128129

Ask questions about any PMCPA case

Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free